Last checked at 20 Dec 2016 15:24
Notification and public disclosure of transactions by persons discharging managerial responsibilities
The attached individual notification made under article 19.1 of the Market Abuse Regulation ("MAR") relates to the transfer of Ordinary Shares in Darhold Limited (which owns 25.00% of the Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC ("Hikma")) from Mazen Darwazah to The TWMR Trust, a trust for the benefit of Mazen Darwazah and his family. This announcement is made in accordance with article 19.3 of MAR.
1 | Details of the person discharging managerial responsibilities / person closely associated | |
a) | Name | Mazen Darwazah |
2 | Reason for the notification | |
a) | Position/status | Executive Vice Chairman / PDMR |
b) | Initial notification /Amendment | Initial notification |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
a) | Name | Hikma Pharmaceuticals PLC ('Hikma') |
b) | LEI | 549300BNS685UXH4JI75 |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each ID Code: GB00B0LCW083 |
b) | Nature of the transaction  | Transfer of 5,449,716 Ordinary Shares of Darhold Limited (who holds 25.00% of the issues share capital of Hikma) to The TWMR Trust, a trust for the benefit of Mazen Darwazah and members of his immediate family. |
c) | Price(s) and volume(s) | Price(s): £0.00 Volume(s): 0 |
d) | Aggregated information | Aggregated volume: 0 Price: £0.00 |
e) | Date of the transaction | 20 December 2016 |
f) | Place of the transaction | Jersey |
Peter Speirs, Company Secretary, Responsible for releasing this announcement
20 December 2016